Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046201A2 Detection and identification of enteric bacteria
06/05/2003WO2003046195A1 Method for generating a site-specific library of variants
06/05/2003WO2003046190A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
06/05/2003WO2003046189A1 Flavivirus vaccine delivery system
06/05/2003WO2003046188A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans
06/05/2003WO2003046187A1 Method for producing a recombinant polypeptide
06/05/2003WO2003046186A1 siRNA EXPRESSION SYSTEM AND METHOD FOR PRODUCING FUNCTIONAL GENE KNOCK-DOWN CELLS USING THE SYSTEM
06/05/2003WO2003046185A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003WO2003046183A2 Streptococcus suis avirulent vaccine and uses in antibiotic design
06/05/2003WO2003046182A1 Human glioma antigen originating in testis
06/05/2003WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells
06/05/2003WO2003046180A2 Human cdnas and proteins and uses thereof
06/05/2003WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof
06/05/2003WO2003046178A1 Processing nucleic acid
06/05/2003WO2003046177A1 Extraction of nucleic acid
06/05/2003WO2003046176A2 Protein-protein interactions in human immunodeficiency virus
06/05/2003WO2003046175A1 Dna construct for assessing thymic function activity and therapeutical uses thereof
06/05/2003WO2003046173A1 siRNA EXPRESSION SYSTEM AND PROCESS FOR PRODUCING FUNCTIONAL GENE-KNOCKDOWN CELLS AND THE LIKE USING THE SAME
06/05/2003WO2003046172A2 Alzheimer’s disease model
06/05/2003WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046167A1 Regulation of human serine/threonine protein kinase
06/05/2003WO2003046166A1 Suicide gene systems
06/05/2003WO2003046165A1 Regulation of human aldose reductase-like protein
06/05/2003WO2003046164A1 Regulation of human prolyl 4-hydroxylase
06/05/2003WO2003046163A2 Multifunctional caffeic acid o-methyltransferase
06/05/2003WO2003046162A2 Process for the production of polypeptides in mammalian cell cultures
06/05/2003WO2003046160A2 Methods of increasing protein expression levels
06/05/2003WO2003046159A1 (r)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same
06/05/2003WO2003046158A1 A method for preparing the recombinant human glucagon like peptide-1 (7-37)
06/05/2003WO2003046155A1 Ϝ-glutamylcysteine-producing yeast
06/05/2003WO2003046154A1 Ϝ-glutamylcysteine-producing yeast and method of screening the same
06/05/2003WO2003046152A2 Molecules for disease detection and treatment
06/05/2003WO2003046150A2 Glycoprotein remodeling using endoglycanases
06/05/2003WO2003046149A2 Methods of using improved polymerases
06/05/2003WO2003046146A2 Compositions and methods of selective nucleic acid isolation
06/05/2003WO2003046142A2 Methods for producing stocks of recombinant aav virions
06/05/2003WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003WO2003046138A2 Genetically stable expression vector
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046134A2 Expression of polypeptides in rod outer segment membranes
06/05/2003WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens
06/05/2003WO2003046132A2 Antisense modulation of myd88 expression
06/05/2003WO2003046131A2 Dnmt3l-related cloning and reproductive methods
06/05/2003WO2003046130A2 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
06/05/2003WO2003046129A2 Compositions for the derivation of germ cells from stem cells and methods of use thereof
06/05/2003WO2003046126A2 Artificial genes for use as controls in gene expression analysis systems
06/05/2003WO2003046125A2 Hin-2 nucleic acid molecules, proteins, antibodies, homologues, receptors, and uses thereof
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046123A2 Mutated gene from corynebacterium glutamicum
06/05/2003WO2003046047A1 Medical polymers and use thereof
06/05/2003WO2003046013A1 Fusion protein having enhanced in vivo activity of erythropoietin
06/05/2003WO2003046007A2 Treatment of micro-organism infection
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045996A1 Chromatographic purification of recombinant human erythropoietin
06/05/2003WO2003045995A2 Cell culture process
06/05/2003WO2003045990A2 Protein-protein interactions involving transforming growth factor beta signalling
06/05/2003WO2003045989A1 A novel homeobox gene
06/05/2003WO2003045988A2 Method to isolate genes involved in aging
06/05/2003WO2003045986A2 Purified polypeptides involved in general metabolism as possible drug targets
06/05/2003WO2003045980A2 Glycopeptide remodeling using amidases
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003WO2003045965A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003WO2003045565A1 Apparatus and method for modification of magnetically immobilized biomolecules
06/05/2003WO2003045499A1 METHODS RELATED TO AN α4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT
06/05/2003WO2003045438A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003WO2003045426A1 T-cell epitodes in carboxypeptidase g2
06/05/2003WO2003045425A1 Muscle transcription factors
06/05/2003WO2003045415A2 Self-assembling p53 peptides as gene delivery vehicles
06/05/2003WO2003045332A2 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003WO2003045323A2 Anti-angiogenesis methods, compositions and uses therefor
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045312A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
06/05/2003WO2003045304A2 Mutable vaccines
06/05/2003WO2003045230A2 Novel compositions and methods for cancer
06/05/2003WO2003045227A2 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
06/05/2003WO2003045137A1 Method of constructing spinal injury model monkey and utilization thereof
06/05/2003WO2003045136A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003WO2003035667A3 Telomerase interference
06/05/2003WO2003027288A9 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
06/05/2003WO2003020952A3 Affinity-shifted probes for quantifying analyte polynucleotides
06/05/2003WO2003012097A3 Methods of inhibiting dna replication
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2003006502A3 Isolation, characterization, and use of a teleost potassium channel
06/05/2003WO2003004656A9 Method for obtaining cells with new properties
06/05/2003WO2003004526A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
06/05/2003WO2003000296A3 Treatment and diagnostic of b cell chronic lymphocytic leukaemia
06/05/2003WO2002102843A3 Gene expression during meningococcus adhesion
06/05/2003WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
06/05/2003WO2002099118A3 Method of identifying a polymorphism in cyp2d6
06/05/2003WO2002092815A3 Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same
06/05/2003WO2002086072A3 Antimicrobial polypeptides and their uses
06/05/2003WO2002083912A3 Production of apomictic seed
06/05/2003WO2002081665A3 Implantation serine proteinases
06/05/2003WO2002081007A3 Methods of isolating blood components using a centrifuge and uses thereof
06/05/2003WO2002079421A3 Transgenic mice containing p19-ptp protein tyrosine phosphatase gene disruptions
1 ... 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 ... 4023